The diverse landscape of dermatologic toxicities of non‐immune checkpoint inhibitor monoclonal antibody‐based cancer therapy

RNH Seervai, SK Friske, EY Chu… - Journal of cutaneous …, 2023 - Wiley Online Library
Background Since their first approval 25 years ago, monoclonal antibodies (mAbs) have
become important targeted cancer therapeutics. However, dermatologic toxicities associated …

Inflamed actinic keratoses as a biomarker in repositioning of chemotherapeutics: a systematic review and meta-analysis

Š Šuler Baglama, I Peteln… - Journal of Dermatological …, 2022 - Taylor & Francis
Background Inflammation of actinic keratoses (AK) was originally described with systemic 5-
fluorouracil, and led to the development of topical fluorouracil. Similar observations using …

Inflammation of actinic keratosis from chemotherapy in a relapsed multiple myeloma patient

AM Khan, TM Ulbeh, J Zonder… - … Case Reports CP, 2023 - casereports.bmj.com
A man in his 60 s with a history of actinic keratosis (AK) and relapsed IgG kappa multiple
myeloma (MM) recently received VD-PACE (bortezomib, dexamethasone, cisplatin …

Treatment of skin disorders with compositions comprising an EGFR inhibitor

M Arkin, M Zighelboim, NOV Ori, O Toledano… - US Patent …, 2023 - Google Patents
2020-01-20 Assigned to SOL-GEL TECHNOLOGIES LTD. reassignment SOL-GEL
TECHNOLOGIES LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …

[PDF][PDF] Inflammation des kératoses actiniques sous docétaxel

N Kluger, L Rentola, P Hervonen… - La Presse …, 2018 - researchportal.helsinki.fi
Inflammation des kératoses actiniques sous docétaxel Kluger, Nicolas Page 1 https://helda.helsinki.fi
Inflammation des kératoses actiniques sous docétaxel Kluger, Nicolas Elsevier Masson …

[引用][C] Inflammation of actinic keratoses after docetaxel.

N Kluger, L Rentola, P Hervonen… - Presse Medicale (Paris …, 2018 - europepmc.org
Inflammation of actinic keratoses after docetaxel. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …